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Results: From	baseline	to	36	months,	children's	BMI	increased	3.0	kg/m2 in individual 
family	and	2.1	kg/m2	 in	group	intervention	(between‐group	−0.9kg/m2,	P	=	0.096).	
Data	were	available	 from	62	children	 (64%).	Between‐group	differences	 in	C	pep‐
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1 | INTRODUC TION
Childhood	 obesity	 is	 associated	 with	 physical	 and	 psychological	
comorbidities	 including	adverse	cardiometabolic	outcomes	such	as	
high	 blood	 pressure,	 dyslipidaemia	 and	 insulin	 resistance.1	 Given	
these	health	risks,	there	is	a	need	for	accessible	and	effective	weight	
management	 interventions	 for	 children	 with	 obesity	 and	 their	
families.2
Modest	 improvements	 in	weight	 and	weight‐related	 outcomes	
have	been	reported	often	 in	response	to	multicomponent	 lifestyle	
interventions	for	treating	childhood	obesity.3,4	A	review	of	lifestyle	





paediatric	 weight	 management	 interventions,	 with	 outcomes	 that	
include	both	weight	and	weight‐related	measures.
Group‐based	 treatment	 of	 childhood	 obesity	may	 be	more	 ef‐
fective	than	individual	approaches.	A	review	suggested	an	enhanced	
effect	of	group	 interventions	at	6‐month	follow‐up,	but	there	was	
no	 evidence	 for	 longer‐term	 effects.4	 Although	 health	 services	 in	
the	primary	care	setting	are	important	for	detecting	and	managing	
obesity	and	 its	complications,2	 there	 is	 little	evidence	of	effective	
primary	care	interventions.5	The	most	effective	weight	management	




The	 Finnmark	Activity	 School	 trial	was	 a	 collaborative	 initiative	
across	primary	and	specialist	care	settings.	The	study	was	designed	
to	treat	childhood	obesity	in	a	region	of	Norway	with	high	prevalence	

















were	 recruited	 through	media	 coverage	 in	 2009‐2010.	Altogether	
97	children	aged	6‐12	years	with	overweight	or	obesity10	 from	six	
municipalities	 in	Finnmark	county,	 and	 the	municipality	of	Tromsø	
were	 randomised	 to	 individual	 family	 intervention	 or	 group	 inter‐
vention	in	a	parallel	design.	The	intervention	lasted	24	months	and	
was	followed	by	a	12‐month	observational	period	that	included	no	
active	 treatment.	The	 trial	was	designed,	 conducted	and	 reported	
in	accordance	with	the	Consolidated	Standards	of	Reporting	Trials	
guidelines.
2.2 | Individual family and group intervention
The	 individual	 family	 intervention	 included	counselling	by	a	nurse,	
consultant	 physician	 and	 nutritionist	 at	 the	 paediatric	 outpatient	





a	 4‐day	 family	 camp.	 Local	 coaches	 with	 experience	 in	 children’s	
sports	 led	 the	PA	sessions.	During	 the	24‐month	 intervention	pe‐
riod,	children	in	individual	family	intervention	were	offered	11	hours	
of	 health‐care	 provider	 contact	while	 their	 peers	 in	 the	 group	 in‐
tervention	 were	 offered	 119	 hours	 of	 contact,	 which	 included	











•	 Long‐term	 data	 are	 needed	 to	 examine	 whether	 im‐
provements	experienced	by	children	enrolled	in	weight	
management	 interventions	 are	maintained	over	 an	ex‐
tended	period.




•	 Data	 from	 both	 groups	 combined	 revealed	 that	 body	
mass	 index	 standard	 deviation	 score	 continued	 to	 de‐
crease	1	year	after	intervention
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providers	 from	 both	 the	 municipalities	 and	 the	 hospital	 partici‐
pated	 in	4,	1.5	day	 training	courses	covering	aspects	of	childhood	
obesity	including	genetics	and	biology,	weight	bias	and	counselling	
skills	 including	 Brief	 Solution	 Focused	 Method	 and	 Motivational	
Interviewing.11‐13	 Providers	 from	 the	 local	 communities	 and	 mul‐
tidisciplinary	hospital	 team	met	quarterly	 (formally)	 and	ad hoc by 
telephone	 and	 video	 conferences	 to	 address	 challenges,	 optimise	
intervention	delivery	and	reinforce	learning	and	networking.



















of	 serum	 triglycerides,	 total	 cholesterol,	 HDL	 cholesterol	 and	
LDL	 cholesterol	 were	 performed	 by	 Siemens	 Advia	 Chemistry	
enzymatic	 methods	 (Siemens	 Healthineers)	 and	 serum	 glucose	




lines.	 Insulin	 resistance	was	estimated	according	 to	 the	homeo‐







dard	 deviation)	 were	 computed	 for	 waist	 circumference,	 systolic	
blood	 pressure,	 serum	 triglycerides	 and	 HDL	 cholesterol,	 HOMA	
and	 CRF.	 High	 values	 reflect	 elevated	 cardiovascular	 risk,	 except	
for	HDL	cholesterol	and	CRF	which	were	subtracted	in	the	contin‐









ent	 samples	 t	 test	 and	 Pearson's	 chi‐square	 tests.	 The	 data	were	
analysed	in	accordance	with	the	original	allocation	independent	of	








indicated	 different	 time	 trends	 between	 the	 intervention	 groups.	
To	control	 for	possible	dependencies	between	 repeated	measures	
a	 random	 intercept	was	 included	 in	 the	model.	 In	 secondary	anal‐







variables	 (e.g.,	metabolic	 syndrome,	BP	≥	90th	 percentile)	 in	 both	







ance	with	 the	Helsinki	 Declaration.	 The	 parents	 provided	written	
informed	consent,	and	all	children	≥12	years	gave	their	assent.
3 | RESULTS
Altogether,	 62	 out	 of	 97	 children	 randomised	 (64%)	 attended	 the	
end	of	follow‐up	visit	at	36	months	and	51	children	(53%)	provided	
blood	 samples	 (Figure	1).	 There	were	no	 significant	differences	 in	
baseline	variables	between	individual	family	intervention	and	group	
intervention	except	 for	 total	cholesterol.	There	were	no	overall	or	





this	 same	period,	BMI	SDS	decreased	by	−0.13	units	 in	 individual	
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F I G U R E  1  Flow	of	participants	in	the	Finnmark	Activity	School.	*	Longitudinal	analyses	including	all	available	data	from	participants	up	
to	the	point	of	study	withdrawal	or	completion
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family	and	by	−0.24	units	in	group	intervention	(−0.11,	95%	CI:	−0.26	
to	0.04,	P	=	0.15,	Figure	2).
























P valuen = 46 n = 45
Age	(y) 10.5	±	1.7 10.1	±	1.7 0.24
Girls/Boys	(n) 22/24 27/18 0.24
Tanner	puberty	stage	≥2	(n;	%) 14	(31.1) 14	(32.6) 0.71
BMI	(kg/m2) 27.6	±	4.3 26.9	±	4.2 0.42
BMI	SD	scorea 2.81	±	0.60 2.76	±	0.58 0.70
Waist	circumference	(cm) 89.2 ± 11.9 87.9	±	12.0 0.62
Systolic	blood	pressure	(mm	Hg) 111.0 ± 11.8 113.3 ± 13.2 0.39
Blood	pressure	≥90th	percentile	(n;	%) 11	(23.9) 15	(33.3) 0.32
Serum	(mmol/L)
Triglycerides 1.12	±	0.69 1.13	±	0.68 0.91
Total	cholesterol 4.96	±	0.89 4.62	±	0.66 0.04
HDL	cholesterol 1.38 ± 0.32 1.26	±	0.37 0.11
LDL	cholesterol 3.30	±	0.94 2.99 ± 0.59 0.06
Insulin	(pmol/L) 97.9	±	58.4 108.1	±	77.5 0.50
Fasting	glucose	(mmol/L) 4.9	±	0.3 5.0	±	0.4 0.19
C	peptide	(pmol/L) 800.6	±	347.0 894.3	±	435.7 0.30
HOMAb 3.08 ± 1.83 3.52	±	2.66 0.38
Cardiorespiratory	fitness	(m)c 631.9	±	114.4 628.0	±	143.4 0.89
Cardiometabolic	sum	scored −0.02	±	0.62 0.06	±	0.71 0.58
Metabolic	syndrome	(n;%)e 3	(7) 11	(24) 0.07

















TA B L E  1  Baseline	characteristics	of	
children	enrolled	in	the	Finnmark	Activity	
School














Our	 findings	 implied	 that	group‐based,	multidisciplinary	 treatment	
that	included	a	large	intervention	dose	did	not	outperform	an	individ‐
ual	 family,	 low‐intensity	 intervention	12	months	after	 intervention	
with	 respect	 to	BMI.	These	 results	contrast	with	previous	 reports	
F I G U R E  2  Mean	BMI	kg/m2	and	BMI	SD	score	from	baseline	to	
36‐mo	follow‐up	by	intervention	group,	Finnmark	Activity	School
TA B L E  2  Changes	in	cardiometabolic	risk	factors	through	36	mo	in	individual	family	and	group	interventions;	Finnmark	Activity	School
 
Mean change from baseline (95 % confidence intervals) Between‐group difference P value
Individual family intervention Group intervention (95% confidence interval) Group × Timea
Waist	circumference	(cm)
3 mo −0.02	(−1.81	to	1.77) −1.46	(−3.23	to	0.31) −1.44(−3.95	to	1.07) 0.26
12 mo 0.95	(−0.89	to	2.79) −0.99	(−2.78	to	0.81) −1.94	(−4.51	to	0.63) 0.14
24	mo 2.8	(0.80	to	4.80) 0.18	(−1.66	to	2.03) −2.62	(−5.34	to	0.10) 0.06
36	mo 4.24	(2.20	to	6.29) 1.99	(−0.05	to	4.02) −2.26	(−5.14	to	0.63) 0.13
Systolic	blood	pressure(mm	Hg)
12 mo −0.6	(−3.9	to	2.7) −1.4	(−4.6	to	1.8) −0.8	(−5.4	to	3.7) 0.72
24	mo 0.6	(−2.9	to	4.1) 1.3	(−2.0	to	4.6) 0.7	(−4.1	to	5.5) 0.78
36	mo 3.2	(−0.4	to	6.9) 3.9	(0.4	to	7.6) 0.7	(−4.4	to	5.9) 0.78
Serum	(mmol/L)
Triglycerides
12 mo −0.11	(−0.34	to	0.12) −0.04	(−0.27	to	0.18) 0.07	(−0.25	to	0.39) 0.68
24	mo −0.07	(−0.32	to	0.17) −0.06	(−0.30	to	0.17) 0.01	(−0.33	to	0.35) 0.1
36	mo 0.13	(−0.13	to	0.4) 0.08	(−0.18	to	0.34) −0.05	(−0.42	to	0.32) 0.77
Total	cholesterol
12 mo −0.31	(−0.50	to	−	0.12) −0.15	(−0.33	to	0.03) 0.16	(−0.10	to	0.42) 0.23
24	mo −0.59	(−0.79	to	−	0.39) −0.32	(−0.51	to	−	0.13) 0.27	(−0.01	to	0.54) 0.06
36	mo −0.82	(−1.04	to	−	0.60) −0.36	(−0.56	to	−	0.15) 0.46	(0.16	to	0.77) 0.003e
HDL	cholesterol
12 mo −0.02	(−0.11	to	0.06) 0.04	(−0.05	to	0.12) 0.06	(−0.06	to	0.17) 0.33
24	mo −0.03	(−0.12	to	0.05) 0.06	(−0.02	to	0.15) 0.1	(−0.03	to	0.22) 0.12
36	mo −0.17	(−0.27	to	−	0.07) 0.01	(−0.08	to	0.11) 0.18	(0.05	to	0.32) 0.008e
(Continues)
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concerning	 differences	 in	 weight	 outcomes	 between	 moderate‐
to‐high	 intensity	 and	very	 low	 intensity	 interventions.20	However,	
children	 in	 the	 individual	 family	 intervention	 received	 more	 than	
standard	care	or	wait‐list	control	group,	which	might	have	reduced	
our	ability	to	detect	between‐group	differences.	Observational	and	
clinical	 studies	have	 reported	 increasing	BMI	SDS	 in	children	with	
overweight	and	obesity	in	the	absence	of	treatment.21,22	Significant	
reductions	in	BMI	SDS	in	both	individual	family	and	group	interven‐
tion	may	 indicate	 that	 both	 interventions	were	 beneficial,	 though	
being	 aware	 the	 limitations	 of	 generalising	 BMI	 SDS	 outcomes.23 
Nevertheless,	 these	 findings	 suggested	 that	 a	 lower	 intensity	 in‐
dividual	 family	 intervention	 yielded	 sustainable	weight	 changes	 in	
children	with	overweight	and	obesity.
4.2 | Cardiometabolic outcomes
The	 improvements	 in	 cardiometabolic	 risk	 factors	 were	 aligned	
with	 findings	 from	 a	 meta‐analysis	 of	 lifestyle	 interventions	 that	
demonstrated	 favourable	 effects	 on	 systolic	 blood	 pressure,	HDL	
cholesterol	 and	 triglycerides	 with	 decreasing	 BMI	 or	 weight.24 
 
Mean change from baseline (95 % confidence intervals) Between‐group difference P value
Individual family intervention Group intervention (95% confidence interval) Group × Timea
LDL	cholesterol
12 mo −0.09	(−0.28	to	0.09) 0.08	(−0.10	to	0.26) 0.18	(−0.08	to	0.43) 0.18
24	mo −0.38	(−0.58	to	−	0.18) −0.13	(−0.32	to	0.05) 0.24	(−0.03	to	0.51) 0.08
36	mo −0.72	(−0.94	to	−	0.50) −0.34	(−0.54	to	−	0.13) 0.38	(0.09	to	0.68) 0.02e
Fasting	glucose	(mmol/L)
12 mo −0.01	(−0.15	to	0.12) −0.11	(−0.24	to	0.02) −0.10	(−	0.29	to	0.09) 0.31
24	mo −0.10	(−0.24	to	0.05) −0.13	(−0.27	to	0.00) −0.04	(−0.24	to	0.16) 0.7
36	mo 0.04	(−0.12	to	0.20) −0.08	(−0.23	to	0.07) −0.12	(−0.34	to	0.10) 0.28
Insulin	(pmol/L)
12 mo 0.8	(−25,4	to	27.0) −2.2	(−28.1	to	23.7) −3.0	(−39.9	to	33.9) 0.88
24	mo 14.7	(−13.1	to	42.5) 2.3	(−23.6	to	28.3) −12.4	(−50.4	to	25.6) 0.52
36	mo 72.3	(41.3	to	103.2) 28.30	(−0.9	to	57.4) −44.0	(−86.6	to	−	1.5) 0.04e
C	peptide	(pmol/L)
12 mo 32.9	(−89.1	to	155.0) −8.3	(−133.5	to	117.0) −41.2	(−216.1	to	133.7) 0.64
24	mo 130.8	(3.2	to	258.3) 11.8	(−113.7	to	137.2) −119.0	(−297.9	to	59.9) 0.19
36	mo 362.8	(220.8	to	504.7) 117.9	(−18.4	to	254.3) −244.9	(−441.7	to	−	48.0) 0.01e
HOMA	scoreb
12 mo 0.01	(−0.88	to	0.90) −0.21	(−1.09	to	0.68) −0.22	(−1.48	to	1.04) 0.73
24	mo 0.42	(−0.53	to	1.37) −0.05	(−0.93	to	0.84) −0.47	(−1.77	to	0.83) 0.48
36	mo 2.33	(1.28	to	3.39) 0.89	(−0.11	to	1.88) −1.44	(−2.90	to	0.01) 0.05
Cardiorespiratory	fitness	(m)c
12 mo 53.3	(21.5	to	85.10) 83.1	(51.9	to	114.2) 29.8	(−14.7	to	74.3) 0.19
24	mo 94.7	(59.0	to	130.3) 133.6	(101.2	to	165.9) 38.9	(−9.3	to	87.0) 0.11
36	mo 130.9	(94.3	to	167.5) 171.5	(135.2	to	207.9) 40.6	(−10.9	to	99.2) 0.12
Cardiometabolic	Sum	scored
12 mo −0.088	(−0.251	to	0.076) −0.215	(−0.373	to	−	0.570) −0.127	(−0.354	to	0.100) 0.27
24	mo −0.047	(−0.231	to	0.137) −0.188	(−0.346	to	−	0.030) −0.141	(−0.383	to	0.102) 0.26







TA B L E  2   (Continued)
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Cardiometabolic	 outcomes	 are	 less	 frequently	 reported	 in	 clinical	




magnitude	 than	 the	 level	≥0.25	suggested	by	Ford	et	al	according	
to	British	 reference,14,26	necessary	 to	achieve	 significant	 improve‐























4.3 | Pooled effects in weight status
Mean	 BMI	 SD	 score	 decreased	 in	 both	 intervention	 groups.	 This	
finding	differs	from	other	reports	that	failed	to	find	sustainable	im‐
provements	 in	weight‐related	outcomes	 after	 the	period	of	 active	
F I G U R E  3  A‐E,	Mean	serum	total	cholesterol,	HDL	cholesterol,	LDL	cholesterol,	insulin	and	C	peptide	from	baseline	to	36‐mo	follow‐up	
by	intervention	group,	Finnmark	Activity	School
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intervention.3,29	 We	 may	 speculate	 if	 the	 collaborative	 approach	


















be	 taken	 into	 account	when	 considering	 the	 statistical	 level	 and	
results.
The	study	was	originally	planned	to	compare	an	intensive	mul‐
tidisciplinary	 intervention	 with	 usual	 care.	 However,	 most	 fami‐
lies	lived	in	small	municipalities	with	only	1‐2	public	health	nurses	
available	 and	 educational	 training	 had	 to	 be	 offered	 to	 all	 staff	
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